The US Food and Drug Administration (FDA) has made the first gene therapy available, marking their approval of a new approach to the treatment of cancer.
People who carry a BsmI single-nucleotide polymorphism are twice as likely to develop nonmelanoma skin cancer as their peers with similar known risk factors, such as older age, male sex, and light eye and skin color.
Researchers have identified a new outcome measurement that should be considered a practical clinical end point for early evaluation in emerging therapies for non-small cell lung cancer.
Sequencing cell-free DNA may be able to provide baseline information on actionable mutations and improve the quality of care in colorectal cancer.
Multiple preoperative indicators may be used as prognostic markers for patients with operable pancreatic ductal adenocarcinoma.
A recent study evaluated survival outcomes after adhering to the NCCN guidelines for time to initiation of postoperative radiation therapy in patients with head and neck squamous cell carcinoma.
Some health care services are rarely offered among older patients in the perioperative period for kidney cancer.
In patients with prostate adenocarcinoma, postdiagnosis statin use was associated with reduced mortality both from prostate cancer and from all causes.
The NCCN has recently released updated guidelines for the treatment of CLL and hairy cell leukemia.